Can a stronger dose of eye injections keep vision stable longer?
NCT ID NCT07390253
First seen Feb 05, 2026 · Last updated May 14, 2026 · Updated 14 times
Summary
This study looks at whether switching people with wet age-related macular degeneration (AMD) from the standard 2mg dose of Aflibercept to a higher 8mg dose can allow longer breaks between eye injections while still keeping vision stable. About 50 adults who have already had at least four injections of the 2mg dose will be followed for 12 months. The goal is to see if the higher dose reduces the number of injections needed without harming eyesight.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NEOVASCULAR (WET) AGE-RELATED MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vienna Institute for Research in Ocular Surgery
Vienna, 1140, Austria
Conditions
Explore the condition pages connected to this study.